|
1
|
Bender E: Epidemiology: The dominant
malignancy. Nature. 513:S2–S3. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research Network:
Author correction comprehensive molecular profiling of lung
adenocarcinoma. Nature. 559:E122018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berge EM and Doebele RC: Targeted
therapies in non-small cell lung cancer: Emerging oncogene targets
following the success of epidermal growth factor receptor. Semin
Oncol. 41:110–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mkrtchian S and Sandalova T: ERp29, an
unusual redox-inactive member of the thioredoxin family. Antioxid
Redox Signal. 8:325–337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang B, Wang M, Yang Y, Wang Y, Pang X,
Su Y, Wang J, Ai G and Zou Z: ERp29 is a radiation-responsive gene
in IEC-6 cell. J Radiat Res. 49:587–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung YC, Wang PW, Pan TL, Bazylak G and
Leu YL: Proteomic screening of antioxidant effects exhibited by
radix salvia miltiorrhiza aqueous extract in cultured rat aortic
smooth muscle cells under homocysteine treatment. J Ethnopharmacol.
124:463–474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dukes AA, Van Laar VS, Cascio M and
Hastings TG: Changes in endoplasmic reticulum stress proteins and
aldolase A in cells exposed to dopamine. J Neurochem. 106:333–346.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheretis C, Dietrich F, Chatzistamou I,
Politi K, Angelidou E, Kiaris H, Mkrtchian S and Koutselini H:
Expression of ERp29, an endoplasmic reticulum secretion factor in
basal-cell carcinoma. Am J Dermatopathol. 28:410–412. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang D and Putti TC: Over-expression of
ERp29 attenuates doxorubicin-induced cell apoptosis through
up-regulation of Hsp27 in breast cancer cells. Exp Cell Res.
316:3522–3531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan LW, Liu DC and Yang ZL: Correlation
of S1P1 and ERp29 expression to progression, metastasis, and poor
prognosis of gallbladder adenocarcinoma. Hepatobiliary Pancreat Dis
Int. 12:189–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng YJ, Tang N, Liu C, Zhang JY, An SL,
Peng YL, Ma LL, Li GQ, Jiang Q, Hu CT, et al: CLIC4, ERp29, and
Smac/DIABLO derived from metastatic cancer stem-like cells stratify
prognostic risks of colorectal cancer. Clin Cancer Res.
20:3809–3817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi L, Wu P, Zhang X, Qiu Y, Jiang W, Huang
D, Liu Y, Tan P and Tian Y: Inhibiting ERp29 expression enhances
radiosensitivity in human nasopharyngeal carcinoma cell lines. Med
Oncol. 29:721–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye W, Zhang R, Hu Y, Xu X and Ying K:
Increased expression of endoplasmic reticulum protein 29 in lung
adenocarcinoma is associated with chemosensitivity to gemcitabine.
Anticancer Drugs. 26:612–619. 2015.PubMed/NCBI
|
|
14
|
Wu P, Zhang H, Qi L, Tang Q, Tang Y, Xie
Z, Lv Y, Zhao S and Jiang W: Identification of ERp29 as a biomarker
for predicting nasopharyngeal carcinoma response to radiotherapy.
Oncol Rep. 27:987–994. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schäfer C, Seeliger H, Bader DC, Assmann
G, Buchner D, Guo Y, Ziesch A, Palagyi A, Ochs S, Laubender RP, et
al: Heat shock protein 27 as a prognostic and predictive biomarker
in pancreatic ductal adenocarcinoma. J Cell Mol Med. 16:1776–1791.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Ziesch A, Hocke S, Kampmann E, Ochs
S, De Toni EN, Göke B and Gallmeier E: Overexpression of heat shock
protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic
cancer cells through S-phase arrest and apoptosis. J Cell Mol Med.
19:340–350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang YH, Belegu V, Zou Y, Wang F, Qian
BJ, Liu R, Dai P, Zhao W, Gao FB, Wang L, et al: Endoplasmic
reticulum protein 29 protects axotomized neurons from apoptosis and
promotes neuronal regeneration associated with erk signal. Mol
Neurobiol. 52:522–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moysan E, Bastiat G and Benoit JP:
Gemcitabine versus modified gemcitabine: A review of several
promising chemical modifications. Mol Pharm. 10:430–444. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou L, Qi L, Jiang L, Zhou P, Ma J, Xu X
and Li P: Antitumor activity of gemcitabine can be potentiated in
pancreatic cancer through modulation of TLR4/NF-κB signaling by
6-shogaol. AAPS J. 16:246–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pauwels B, Korst AE, Lardon F and
Vermorken JB: Combined modality therapy of gemcitabine and
radiation. Oncologist. 10:34–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang C, Wang JJ, Jing G, Li J, Jin C, Yu
Q, Falkowski MW and Zhang SX: Erp29 attenuates cigarette smoke
extract-induced endoplasmic reticulum stress and mitigates tight
junction damage in retinal pigment epithelial cells. Invest
Ophthalmol Vis Sci. 56:6196–6207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu R, Zhao W, Zhao Q, Liu SJ, Liu J, He
M, Xu Y, Wang W, Liu W, Xia QJ, et al: Endoplasmic reticulum
protein 29 protects cortical neurons from apoptosis and promoting
corticospinal tract regeneration to improve neural behavior via
caspase and erk signal in rats with spinal cord transection. Mol
Neurobiol. 50:1035–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morgan MA, Parsels LA, Parsels JD,
Mesiwala AK, Maybaum J and Lawrence TS: Role of checkpoint kinase 1
in preventing premature mitosis in response to gemcitabine. Cancer
Res. 65:6835–6842. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luk PP, Galettis P and Links M: ERK
phosphorylation predicts synergism between gemcitabine and the
epidermal growth factor receptor inhibitor AG1478. Lung Cancer.
73:274–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calderwood SK and Gong J: Heat shock
proteins promote cancer: It's a protection racket. Trends Biochem
Sci. 41:311–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taylor RP and Benjamin IJ: Small heat
shock proteins: A new classification scheme in mammals. J Mol Cell
Cardio. 38:433–444. 2005. View Article : Google Scholar
|
|
27
|
Nakashima M, Adachi S, Yasuda I, Yamauchi
T, Kawaguchi J, Itani M, Yoshioka T, Matsushima-Nishiwaki R, Hirose
Y, Kozawa O, et al: Phosphorylation status of heat shock protein 27
plays a key role in gemcitabine-induced apoptosis of pancreatic
cancer cells. Cancer Lett. 313:218–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zoubeidi A and Gleave M: Small heat shock
proteins in cancer therapy and prognosis. Int J Biochem Cell Bio.
44:1646–1656. 2012. View Article : Google Scholar
|
|
29
|
Kostenko S and Moens U: Heat shock protein
27 phosphorylation: Kinases, phosphatases, functions and pathology.
Cell Mol Life Sci. 66:3289–3307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Köpper F, Bierwirth C, Schön M, Kunze M,
Elvers I, Kranz D, Saini P, Menon MB, Walter D, Sørensen CS, et al:
Damage-induced DNA replication stalling relies on MAPK-activated
protein kinase 2 activity. Proc Natl Acad Sci USA. 110:16856–16861.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Evans J, Ko Y, Mata W, Saquib M, Eldridge
J, Cohen-Gadol A, Leaver HA, Wang S and Rizzo MT: Arachidonic acid
induces brain endothelial cell apoptosis via p38-MAPK and
intracellular calcium signaling. Microvasc Res. 98:145–158. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim J, Jung H, Lim W, Kim S, Ko Y, Karna S
and Kim O, Choi Y, Choi H and Kim O: Down-regulation of heat-shock
protein 27-induced resistance to photodynamic therapy in oral
cancer cells. J Oral Pathol Med. 42:9–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z, Li D, Zheng X, Wang E and Wang J:
Selective induction of apoptosis: Promising therapy in pancreatic
cancer. Curr Pharm Des. 19:2259–2268. 2013. View Article : Google Scholar : PubMed/NCBI
|
